US Generics Industry Group Gets New Board Chair, Begins Search For New CEO In Earnest

Christine Baeder’s departure from Teva means transition at the Association for Accessible Medicines’ board of directors as well; Sandoz’s Keren Haruvi becomes chair. The group also started looking for a new permanent CEO to replace Dan Leonard, who left AAM in December 2022.

Christine Baeder of Teva and the AAM
Christine Baeder (pictured) has departed both Teva and the AAM • Source: Teva

More from Leadership

More from Generics Bulletin